Curis | Capitale Ordinario





Capitale Ordinario Cambiamento Data
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bayer EUR 982.42M 0 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
CSL USD 482.13M 93.87M 2025-12
Curis USD 59K 934K 2023-09
Eli Lilly USD 946.83M 354.23M 2025-06
Exelixis USD 268.1M 2.03M 2025-09
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Incyte USD 198.46M 2.33M 2025-12
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.94B 23.4M 2025-06
Pfizer USD 5.69B 1000K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Takeda JPY 1.58B 2K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Verastem USD 4K 1000 2024-09
Xoma USD 87K 1000 2024-06


Curis Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.